SARS and Avian Flu Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SARS and Avian Flu

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Maurice Winn who wrote (779)	5/11/2003 12:54:41 PM
From: Biomaven	Read Replies (1) of 4232

Maurice: RSV is Respiratory Syncytial Virus. It's a bug that in adults usually produces only mild symptoms but can also produce a pneumonia very similar to that of SARS. It's predominantly a problem in infants, particularly premature infants. Over 100k infants are hospitalized each year with RSV, of which about 2% die. MEDI produces an antibody (Synagis) that is given prophylactically to premature infants. It is very expensive ($5k for the multiple monthly injections needed) but likely worth it. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next